WBX +40.8% Leads EPS Revision Winners; NMAX Surges on 217.8pp EPS Upgrade
Stocks with upward EPS estimate revisions delivered strong gains. WBX jumped 40.8% after analysts raised forward EPS growth from 50.6% to 61.3%, reinforced by an equity raise and Q2 results announcement. RBRK gained 20.3% on 106.4% EPS growth estimate, while MRNA rose 18.6% on 45.4% growth. VERX and NMAX also rallied 17.5% and 16.7% respectively, with NMAX seeing a staggering 217.8 percentage point EPS revision.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| WBX | Technology | 2026-06-30 | +10.6pp | +40.8% |
| RBRK | Technology | 2026-06-28 | N/A | +20.3% |
| MRNA | Healthcare | 2026-06-28 | N/A | +18.6% |
| VERX | Technology | 2026-06-29 | N/A | +17.5% |
| NMAX | Communication Services | 2026-06-28 | +217.8pp | +16.7% |
Why did WBX stock jump in July 2026?
WBX jumped 40.8% (from $3.82 to $5.38) after analysts raised its next-year EPS growth estimate from 50.6% to 61.3% on June 30.
The revision came amid strong momentum in the EV charging sector. Wallbox completed an equity raise of ~11.8 million on July 2 and announced Q2 2026 financial results timing on July 7, reinforcing confidence in its growth trajectory. The screener detected the revision early, capturing the stock before the 40.8% rally.
WBX EPS revision history → · Screener snapshot from 2026-06-30 →
FAQ: WBX
Why did WBX stock jump in June 2026?
WBX jumped 40.8% after analysts raised its next-year EPS growth estimate from 50.6% to 61.3% on June 30, later supported by an equity raise and Q2 earnings announcement.
Is WBX a buy after the 40% rally?
The EPS revision and catalyst news suggest confidence, but investors should consider the stock's valuation and upcoming Q2 results before buying.
What caused WBX's surge?
The surge was driven by an upward earnings estimate revision of 10.6 percentage points, followed by an equity raise and scheduled Q2 financial results.
Why did RBRK stock jump in July 2026?
RBRK jumped 20.3% (from $72.33 to $87.04) after analysts revised its next-year EPS growth estimate to 106.4% on June 28.
The revision reflects growing demand for Rubrik's data security solutions. No specific earnings news was announced, but the EPS growth estimate of over 100% signals robust margin expansion expectations. The screener detected the upgrade early, and the stock steadily climbed.
RBRK EPS revision history → · Screener snapshot from 2026-06-28 →
FAQ: RBRK
Why did RBRK stock jump in late June 2026?
RBRK jumped 20.3% after analysts raised its next-year EPS growth estimate to 106.4% on June 28, pointing to strong earnings momentum.
Is RBRK a buy after the 20% rally?
With a 106.4% EPS growth estimate, the stock appears attractively priced, but investors should monitor execution risks in the cybersecurity market.
What is RBRK's EPS growth estimate?
RBRK's next-year EPS growth estimate stands at 106.4% as of the revision on June 28, 2026.
Why did MRNA stock jump in July 2026?
MRNA jumped 18.6% (from $67.27 to $79.77) after analysts revised its next-year EPS growth estimate to 45.4% on June 28.
The revision comes as Moderna expands beyond COVID-19 vaccines into RSV and flu treatments. No earnings news was released, but the positive estimate change reflects improving pipeline prospects. The stock rallied steadily following detection.
MRNA EPS revision history → · Screener snapshot from 2026-06-28 →
FAQ: MRNA
Why did MRNA stock jump in June 2026?
MRNA jumped 18.6% after analysts raised its next-year EPS growth estimate to 45.4% on June 28, driven by pipeline optimism.
What caused MRNA's surge?
The surge was triggered by a positive EPS estimate revision to 45.4% growth, with no additional news catalysts required.
Is MRNA a buy after the 18% rally?
With a 45.4% EPS growth estimate and expanding pipeline, MRNA may be a buy, but investors should consider regulatory milestones.
Why did VERX stock jump in July 2026?
VERX jumped 17.5% (from $11.40 to $13.40) after analysts revised its next-year EPS growth estimate to 29.1% on June 29.
Vertex provides tax technology solutions, and the upward revision signals market share gains. No news was announced, but the EPS growth estimate improvement caught the screener's attention. The stock climbed 17.5% over the following week.
VERX EPS revision history → · Screener snapshot from 2026-06-29 →
FAQ: VERX
Why did VERX stock jump in June 2026?
VERX jumped 17.5% after analysts raised its next-year EPS growth estimate to 29.1% on June 29, indicating improved profitability.
What caused VERX's surge?
The surge followed an upward EPS estimate revision with no specific news catalysts, purely driven by margin expectations.
Is VERX a buy after the rally?
The 29.1% EPS growth estimate supports upside, but the stock is up 17.5% — investors may wait for pullbacks.
Why did NMAX stock jump in July 2026?
NMAX jumped 16.7% (from $7.49 to $8.74) after analysts raised its next-year EPS growth estimate from 159.1% to 376.9% on June 28.
This massive 217.8 percentage point revision dwarfed other stocks in the screener. As a media company, Newsmax is benefiting from increasing viewership and ad revenue. No news was announced, but the estimate change alone drove a 16.7% gain.
NMAX EPS revision history → · Screener snapshot from 2026-06-28 →
FAQ: NMAX
Why did NMAX stock jump in June 2026?
NMAX jumped 16.7% after analysts dramatically raised its next-year EPS growth estimate from 159.1% to 376.9% on June 28.
What is NMAX's EPS growth estimate?
NMAX's next-year EPS growth estimate surged to 376.9% following a 217.8 percentage point revision on June 28, 2026.
What caused NMAX's surge?
The surge was caused by an exceptionally large upward EPS estimate revision, implying more than triple the previously expected earnings growth.
Today's top performers highlight that upward EPS estimate revisions remain a powerful catalyst, even without accompanying news. Technology and healthcare stocks led, with NMAX's outlier revision underscoring the market's appetite for dramatic earnings turnaround stories.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →